Previous Article | Next Article ![]()
Molecular and Cellular Biology, September 2000, p. 6704-6711, Vol. 20, No. 18
Cellular Stress Group, MRC Clinical Sciences
Centre, Imperial College School of Medicine, Hammersmith Hospital,
London W12 0NN, United Kingdom,1 and
U465 INSERM, Centre Biomédical des Cordeliers,
F-75270 Paris Cedex 06,2 and U25 INSERM,
Faculté de Médecine Necker-Enfants Malades, 75730 Paris
Cedex 15,3 France
Received 3 April 2000/Returned for modification 19 May
2000/Accepted 20 June 2000
In the liver, glucose induces the expression of a number of genes
involved in glucose and lipid metabolism, e.g., those encoding L-type
pyruvate kinase and fatty acid synthase. Recent evidence has indicated
a role for the AMP-activated protein kinase (AMPK) in the inhibition of
glucose-activated gene expression in hepatocytes. It remains unclear,
however, whether AMPK is involved in the glucose induction of these
genes. In order to study further the role of AMPK in regulating gene
expression, we have generated two mutant forms of AMPK. One of these
(
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of the Role of AMP-Activated
Protein Kinase in the Regulation of Glucose-Activated Gene
Expression Using Constitutively Active and Dominant Negative
Forms of the Kinase
1312) acts as a constitutively active kinase, while the
other (
1DN) acts as a dominant negative inhibitor of endogenous
AMPK. We have used adenovirus-mediated gene transfer to express these
mutants in primary rat hepatocytes in culture in order to determine
their effect on AMPK activity and the transcription of
glucose-activated genes. Expression of
1312 increased
AMPK activity in hepatocytes and blocked completely the induction of a
number of glucose-activated genes in response to 25 mM glucose. This
effect is similar to that observed following activation of AMPK by
5-amino-imidazolecarboxamide riboside. Expression of
1DN markedly
inhibited both basal and stimulated activity of endogenous AMPK but had
no effect on the transcription of glucose-activated genes. Our results
suggest that AMPK is involved in the inhibition of glucose-activated
gene expression but not in the induction pathway. This study
demonstrates that the two mutants we have described will provide
valuable tools for studying the wider physiological role of AMPK.
*
Corresponding author. Mailing address: Cellular Stress
Group, MRC Clinical Sciences Centre, Imperial College School of
Medicine, Hammersmith Hospital, DuCane Road, London W12 0NN, United
Kingdom. Phone: 44 (0)20 8383 4313. Fax: 44 (0)20 8383 2028. E-mail:
dcarling{at}csc.mrc.ac.uk.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|